Company Profiles

driven by the PitchBook Platform

ACEA Biosciences

ACEA Biosciences
2002 FOUNDED
PRIVATE STATUS
201-500 EMPLOYEES
Series E LATEST DEAL TYPE
$30M LATEST DEAL AMOUNT
$42.8M TOTAL AMOUNT RAISED
Description

Developer of cell analysis instruments for life science research and clinical diagnostics. The company uses microelectrodes in automated high-throughput plate formats to develop instruments for real time cell analysis which helps in monitoring of cell proliferation, cell size, cell-substrate attachment quality and cell invasion.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
6779 Mesa Ridge Road
Suite 100
San Diego, CA 92121
United States

+1 (858) 724-0928
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ACEA Biosciences’s full profile, request a free trial.

ACEA Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series E) 06-Nov-2015 $30M $42.8M 00000 Completed Clinical Trials - Phase 1
5. Grant 03-Jul-2013 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 10-Sep-2007 00.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 00.000 00.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) $1.85M $4.15M $16.3M Completed
1. Early Stage VC (Series A) $2.3M $2.3M $6.11M Completed
To view this company’s complete deal history including valuation and funding request access »

ACEA Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series D 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B 1,589,690 $0.001000 4% $1.16 $1.16 1x $1.16 7.98%
Series A 3,199,414 $0.001000 4% $0.95 $0.95 1x $0.95 16.06%
To view this company’s complete Cap Table request access »

ACEA Biosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Lilly Asia Ventures Venture Capital Minority 000 0000 000000 0
Qiming Venture Partners Venture Capital Minority 000 0000 000000 0
U.S. Environmental Protection Agency Other 000 0000 000000 0

You’re viewing 3 of 3 investors.

ACEA Biosciences Executive Team (8)

Name Title Board
Seat
Contact
Info
Xiao Xu President & Co-Chief Executive Officer
James O'Connell Co-Chief Executive Officer
Xiaobo Wang Chief Technology Officer & Vice President
Gang Pan Marketing Manager
Robert Wang Ph.D Vice President of Commercialisation
You’re viewing 5 of 8 executives. Get the full list »

ACEA Biosciences Board Members (2)

Name Representing Role Since Contact
Info
Feng Lin ACEA Biosciences Co-Founder & Co-Chairman 000 0000
Lin Jixun ACEA Biosciences Co-Founder & Co-Chairman 000 0000

You’re viewing 2 of 2 board members.